arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Ascend Wellness Holdings, Inc.

AAWH
Price unavailable
Materials ·Medicinal Chemicals & Botanical Products ·USMedicinal Chemicals & Botanical Products
26 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
59
Health
Fair
Neutral
auto_awesome

Analytical Summary

Ascend Wellness Holdings, Inc. demonstrates solid fundamentals with strength in Return on Common Equity (%). However, watch Profit Margin (%) which shows concerning trends. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap
Dividend Yield
Revenue Growth -8.6%
Op. Margin 2.2%
ROIC 1.8%
FCF / Share $-0.12
Trailing P/E
Price / Book
FCF Yield
Debt / Equity -4.16
info Valuation on last close.

26-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$116.93M
↓ -8.6%
Net Income Profit after all expenses
$-29.49M
↓ -53.1%
Operating Margin Operating profit as % of sales
2.2%
↑ +115.3% 22th
FCF / Share Free cash flow per share
$-0.12
↓ -5044.7%
Long-Term Debt Long-term obligations
$318.88M
— -0.2%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
21
Returns
100
Financial Health
74
Cash Quality
19

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters